164Information for CHO about monitored medicines supplied

164 Information for CHO about monitored medicines supplied during consultations—Act, s 31 (2) (b) and (4), def required information (1) This section applies if a prescriber supplies a monitored medicine for human use during a consultation. Note Supply does not include administer (see Act, s 24). (2) The prescriber must, not later than 7 days after the end of the month when the monitored medicine is supplied, give the chief health officer the following information in writing: (a) the prescriber’s name, business address and telephone number; (b) the name, date of birth and address of the person to whom the medicine is supplied; (c) the date of supply; (d) the monitored medicine, and the form, strength and quantity of the medicine, supplied.